Skip to content
sellModerate cluster of 710b5-1 plan

Jeffrey B. Mirviss sold $1.4M of BSX

EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP. 13,022 shares at an average of $105.06, traded Feb 12, 2025, filed Feb 13, 2025.

Warning score
45
Value
$1.4M
13,022 shares
Holdings after
28,454
-31% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Officer
    +15
  • Trade size
    $1.4M at market
    +25
  • Share of holdings sold
    Sold 31% of holdings
    +10
  • Cluster
    7 insiders selling within 14 days
    +15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

BSXOct 9, 2026 · close 42.73
Since filing Feb 13, 2025: -59.7%SPY +30.2% · excess -89.9%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001225208-25-001685, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 11, 2025AGrant or award
Common Stock10b5-1
+23,760$0.00$052,214Feb 13, 2025
Feb 11, 2025FTax withholding
Common Stock10b5-1
-10,738$105.98$1.1M41,476Feb 13, 2025
Feb 12, 2025SOpen-market sale
Common Stock10b5-1
-13,022$105.06$1.4M28,454Feb 13, 2025

Related signals

Other insiders at BOSTON SCIENTIFIC CORP and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
20Weak
BSXsell10b5-1
BOSTON SCIENTIFIC CORP
Michael F Mahoney
Chairman, President & CEO
$15M
160,901 shares
-10%
25Weak
BSXsell10b5-1
BOSTON SCIENTIFIC CORP
Arthur C Butcher
EVP& Grp Pres, MedSurg & APAC
$1.8M
17,313 shares
-42%
38Weak
BSXsell 210b5-1
BOSTON SCIENTIFIC CORP
Ellen M Zane
director
$1.3M
12,891 shares
-35%
18Weak
BSXsell 210b5-1
BOSTON SCIENTIFIC CORP
Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
$5.0M
50,000 shares
-22%
38Weak
BSXsell 210b5-1
BOSTON SCIENTIFIC CORP
Ellen M Zane
director
$1.3M
12,891 shares
-35%
10Weak
BSXsell10b5-1
BOSTON SCIENTIFIC CORP
Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
$4.9M
50,000 shares
-22%
10Weak
BSXsell10b5-1
BOSTON SCIENTIFIC CORP
Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
$5.3M
50,000 shares
-22%
40Moderate
BSXsell 410b5-1
BOSTON SCIENTIFIC CORP
Arthur C Butcher
EVP& Grp Pres, MedSurg & APAC
$1.8M
17,313 shares
-42%
25Weak
BSXsell 410b5-1
BOSTON SCIENTIFIC CORP
Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
$5.2M
50,000 shares
-22%
64Notable
BSXsell 4
BOSTON SCIENTIFIC CORP
Yoshiaki Fujimori
director
$310k
2,901 shares
-58%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jeffrey B. Mirviss sold $1.4M of BSX | InsiderTell